List of insiders holdings for NOVELION THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Aegerion Pharmaceuticals Inc. 10% Owner | 2016-06-24 12:32:38 | 13,109,202 0 | 13,109,202 | Form 13D |
| NB Public Equity K/S NB Public Equity Komplementar ApS Madsen Cora Hansen Christian Schonharting Florian 10% Owner | 2009-02-06 16:11:02 | 6,513,579 0 | 6,513,579 | Form 13G |
| SIMONS JAMES H RENAISSANCE TECHNOLOGIES LLC Please see footnote (1) | 2009-03-17 18:23:16 | 5,665,849 0 | 5,665,849 | Form 13G |
| STONEPINE CAPITAL L.P. 10% Owner | 2019-12-12 16:25:09 | 3,909,207 0 | 3,909,207 | Form 4 |
| JANA PARTNERS LLC 10% Owner | 2007-12-03 17:04:18 | 3,577,269 0 | 3,577,269 | Form 13D |
| Broadfin Healthcare Master Fund Ltd Broadfin Capital LLC KOTLER KEVIN 10% Owner | 2020-01-15 17:25:08 | 2,541,222 0 | 2,541,222 | Form 3 |
| LEVY JULIA Director | 2006-03-15 14:33:01 | 759,730 0 | 759,730 | Form 4 |
| Aryeh Jason Director | 2017-05-17 17:43:02 | 242,433 150,300 | 392,733 | Form 4 |
| DUNCAN MICHAEL R Manager - Atrix Operations | 2006-03-15 16:15:14 | 320,829 0 | 320,829 | Form 4 |
| Panigrahi Dipak SVP, R&D and CMO | 2010-05-25 21:49:59 | 300,000 0 | 300,000 | Form 4 |
| Assaly Dori Christine SVP, Legal & Corp. Secy. | 2016-06-21 21:09:36 | 280,000 0 | 280,000 | Form 4 |
| Janes Lana Elizabeth Sr. Vice Pres. - See Remarks | 2016-06-21 21:03:02 | 280,000 0 | 280,000 | Form 4 |
| Ibbott William Glen SVP, Finance & CFO | 2016-06-21 21:16:59 | 280,000 0 | 280,000 | Form 4 |
| Muller Christopher A. See Remarks | 2012-04-17 17:58:12 | 250,000 0 | 250,000 | Form 4 |
| BUTCHOFSKY ROBERT President and CEO | 2012-03-21 19:50:50 | 169,197 0 | 169,197 | Form 4 |
| Smith Michael P VP, Business Development | 2006-03-15 16:28:31 | 140,000 0 | 140,000 | Form 4 |
| CADDEN SUZANNE SVP, Development | 2011-09-21 16:00:12 | 120,000 0 | 120,000 | Form 3 |
| HACKMAN JEFFREY C.O.O. and Interim C.E.O. | 2018-11-05 18:35:15 | 110,351 0 | 110,351 | Form 4 |
| Lussow Alexander R Sr. VP, Bus. Dev. & Comm. Op. | 2013-11-25 17:58:57 | 100,000 0 | 100,000 | Form 4 |
| Jagpal Sukhi Chief Financial Officer | 2013-07-17 17:41:37 | 100,000 0 | 100,000 | Form 4 |
| Menes Remi A See Remarks | 2016-12-27 16:03:02 | 97,400 0 | 97,400 | Form 4 |
| Nelson Cameron Senior VP, Finance and CFO | 2011-05-27 21:39:22 | 90,000 0 | 90,000 | Form 4 |
| Meckler Jeffrey A Director | 2016-06-21 21:06:26 | 78,400 0 | 78,400 | Form 4 |
| KOZARICH JOHN W Director | 2016-06-21 21:03:31 | 78,400 0 | 78,400 | Form 4 |
| WOOD JACK Director | 2011-05-27 21:34:42 | 52,500 0 | 52,500 | Form 4 |
| CROSSGROVE PETER A Director | 2011-05-27 21:43:10 | 52,500 0 | 52,500 | Form 4 |
| CORRIGAN MARK Director | 2018-08-13 16:30:34 | 50,000 0 | 50,000 | Form 4 |
| CARTER BRUCE L A Director | 2011-05-27 21:37:07 | 45,000 0 | 45,000 | Form 4 |
| Massey Ian J Director | 2011-05-27 21:37:55 | 45,000 0 | 45,000 | Form 4 |
| Stewart Murray Executive Vice President, R&D | 2018-02-14 07:01:53 | 45,000 0 | 45,000 | Form 4 |
| NEWELL WILLIAM J Sr. VP & Chief Bus. Officer | 2005-03-10 13:30:27 | 30,000 0 | 30,000 | Form 4 |
| DOTY MICHAEL J Sr. VP & CFO | 2005-03-10 13:30:15 | 30,000 0 | 30,000 | Form 4 |
| ANIDO VICENTE JR Director | 2013-07-17 17:55:19 | 29,500 0 | 29,500 | Form 4 |
| FALBERG KATHRYN E Director | 2011-05-27 21:39:45 | 22,500 0 | 22,500 | Form 4 |
| Szela Mary T Chief Executive Officer | 2017-05-11 16:02:57 | 17,648 0 | 17,648 | Form 4 |
| Chan Barbara Y See Remarks | 2019-09-26 18:29:54 | 16,387 0 | 16,387 | Form 4 |
| TURNER JOSEPH L Director | 2011-05-27 21:36:13 | 15,000 0 | 15,000 | Form 4 |
| LUPINI LINDA Senior VP, HR & Org. Dev. | 2012-08-15 19:03:48 | 15,000 0 | 15,000 | Form 4 |
| PRICE MICHAEL DENNIS Chief Financial Officer | 2019-09-26 18:30:09 | 14,111 0 | 14,111 | Form 4 |
| CORMATRIX CARDIOVASCULAR INC Director | 2012-07-12 20:25:47 | 11,000 0 | 11,000 | Form 4 |
| Thomas John C Director | 2018-08-13 16:30:34 | 10,000 0 | 10,000 | Form 4 |
| DiPaolo Mark Director | 2018-08-13 16:31:20 | 10,000 0 | 10,000 | Form 4 |
| ORLOFF JOHN J Director | 2018-08-13 16:31:19 | 10,000 0 | 10,000 | Form 4 |
| Sabba Stephen L Director | 2018-08-13 16:31:05 | 10,000 0 | 10,000 | Form 4 |
| Stern Donald K Director | 2018-08-13 16:30:51 | 10,000 0 | 10,000 | Form 4 |
| Bruhn Suzanne Louise Director | 2018-08-13 16:30:51 | 10,000 0 | 10,000 | Form 4 |
| Plutzky Jorge MD Director | 2016-12-27 16:08:32 | 9,600 0 | 9,600 | Form 4 |
| COX GEOFFREY F Director | 2016-12-27 16:11:17 | 9,600 0 | 9,600 | Form 4 |
| VANLENT ANNE Director | 2016-12-27 16:10:32 | 9,600 0 | 9,600 | Form 4 |
| HASTINGS PAUL J President & CEO | 2005-04-29 15:47:39 | 9,500 0 | 9,500 | Form 4 |
| LIVINGSTON PHILIP B Director | 2007-05-21 17:54:56 | 7,500 0 | 7,500 | Form 4 |
| VUTURO GEORGE J Director | 2005-03-10 19:09:21 | 7,500 0 | 7,500 | Form 4 |
| Hao Yong Vice President, Development | 2009-05-26 20:51:27 | 6,591 0 | 6,591 | Form 4/A |
| PERRY GREGORY D See Remarks | 2017-05-11 16:02:43 | 6,469 0 | 6,469 | Form 4 |
| VIETOR RICHARD R Director | 2007-10-30 17:30:07 | 5,448 0 | 5,448 | Form 4 |
| Harshbarger Benjamin See Remarks | 2019-05-13 16:05:39 | 3,683 0 | 3,683 | Form 4 |
| AZAB MOHAMMAD Exec VP-R&D, CMO | 2005-05-25 15:58:33 | 1,200 0 | 1,200 | Form 4 |
| Louis Roger See Remarks | 2019-05-13 16:06:39 | 1,162 0 | 1,162 | Form 4 |
| SMITH SANDFORD D Director | 2017-02-03 16:02:03 | 1,048 0 | 1,048 | Form 4/A |
| Buono Linda Sr. VP, Human Resources | 2019-05-13 16:06:09 | 570 0 | 570 | Form 4 |
| REDENBARGER JAMES Vice President Operations | 2005-05-12 14:06:21 | 400 0 | 400 | Form 4 |
| CLARKE C BOYD Former Director Director | 2012-07-11 13:19:25 | 0 0 | 0 | Form 4 |
| SCOTT E DUFF Director | 2008-02-07 12:55:19 | 0 0 | 0 | Form 5 |
| NB Public Equity K/S Schonharting Florian Madsen Cora 10% Owner | 2020-01-21 14:10:54 | 0 0 | 0 | Form 13G |
| HAYES THERESE VP, Investor Relations | 2008-07-31 21:14:00 | 0 0 | 0 | Form 4 |
| MENDELSON ALAN C Director | 2008-05-22 18:17:26 | 0 0 | 0 | Form 4 |
| AUXILIUM PHARMACEUTICALS INC 10% Owner | 2014-07-07 16:01:04 | 0 0 | 0 | Form 3 |
| NB Public Equity K/S Schonharting Florian 10% Owner | 2020-01-21 14:10:54 | 0 0 | 0 | Form 13G |
| Axial Capital Master L.P. 10% Owner | 2015-06-17 11:15:06 | 0 0 | 0 | Form 4 |
| AXIAL CAPITAL MANAGEMENT LLC ANDERSEN MARC ASSOULINE ELIAV 10% Owner | 2015-06-17 16:19:59 | 0 0 | 0 | Form 13D |
| Wattier Daniel J VP, Marketing & Sales | 2008-04-02 16:38:43 | 0 0 | 0 | Form 4 |
| CURAUDEAU ALAIN Sr. VP, Portfolio & Proj. Mgmt | 2008-03-06 19:53:24 | 0 0 | 0 | Form 4 |
| Grove Janet P VP & Corporate Counsel | 2008-02-13 12:48:30 | 0 0 | 0 | Form 4 |
| NB Public Equity K/S Hansen Christian Schonharting Florian 10% Owner | 2020-01-21 14:10:54 | 0 0 | 0 | Form 13G |
| O Callaghan Peter J Sen. VP, Corp Dev/Gen Counsel | 2007-05-23 15:14:23 | 0 0 | 0 | Form 4 |
| HENRIKSEN RONALD D Director | 2007-06-19 14:39:53 | 0 0 | 0 | Form 4 |